These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11411746)

  • 1. Insulin resistance and cardiovascular disease.
    Egan BM; Greene EL; Goodfriend TL
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):116S-125S. PubMed ID: 11411746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonesterified fatty acids in blood pressure control and cardiovascular complications.
    Egan BM; Greene EL; Goodfriend TL
    Curr Hypertens Rep; 2001 Apr; 3(2):107-16. PubMed ID: 11276390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster.
    Egan BM; Lu G; Greene EL
    Prostaglandins Leukot Essent Fatty Acids; 1999; 60(5-6):411-20. PubMed ID: 10471131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin resistance and renin-angiotensin-aldosterone system].
    Saitoh S
    Nihon Rinsho; 2009 Apr; 67(4):729-34. PubMed ID: 19348235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and the sympathetic nervous system.
    Egan BM
    Curr Hypertens Rep; 2003 Jun; 5(3):247-54. PubMed ID: 12724058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.
    Zhou MS; Schulman IH; Zeng Q
    Vasc Med; 2012 Oct; 17(5):330-41. PubMed ID: 22814999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p66(Shc)-induced redox changes drive endothelial insulin resistance.
    Paneni F; Costantino S; Cosentino F
    Atherosclerosis; 2014 Oct; 236(2):426-9. PubMed ID: 25150941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular signaling pathways in the metabolic syndrome.
    Rakugi H; Kamide K; Ogihara T
    Curr Hypertens Rep; 2002 Apr; 4(2):105-11. PubMed ID: 11884265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidinediones--tools for the research of metabolic syndrome X.
    Komers R; Vrána A
    Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. El papel de los ácidos grasos libres en la resistencia a la insulina.
    Vázquez-Jiménez JG; Roura-Guiberna A; Jiménez-Mena LR; Olivares-Reyes JA
    Gac Med Mex; 2017; 153(7):852-863. PubMed ID: 29414963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
    Sydow K; Mondon CE; Cooke JP
    Vasc Med; 2005 Jul; 10 Suppl 1():S35-43. PubMed ID: 16444867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of insulin resistance and hypertension by voluntary exercise training in the TG(mREN2)27 rat.
    Kinnick TR; Youngblood EB; O'Keefe MP; Saengsirisuwan V; Teachey MK; Henriksen EJ
    J Appl Physiol (1985); 2002 Aug; 93(2):805-12; discussion 797. PubMed ID: 12133896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of angiotensin in the metabolic syndrome and cardiovascular complications].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2002 Oct; 60(10):1898-903. PubMed ID: 12397681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct renin inhibitor prevents and ameliorates insulin resistance, aortic endothelial dysfunction and vascular remodeling in fructose-fed hypertensive rats.
    Chou CL; Pang CY; Lee TJ; Fang TC
    Hypertens Res; 2013 Feb; 36(2):123-8. PubMed ID: 22895064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin-angiotensin system and insulin resistance.
    Liu Z
    Curr Diab Rep; 2007 Feb; 7(1):34-42. PubMed ID: 17254516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between insulin resistance and endothelium-dependent vasodilatation in obese subjects].
    Yu YR; Li HL; Yu HL; Wang C; Pu S
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1467-70. PubMed ID: 14521722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.